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Although respiratory tract defects that result from disruption of retinoic acid (RA) signaling have been widely reported, the mechanism by
which endogenous RA regulates early lung morphogenesis is unknown. Here, we provide novel evidence that a major role for RA is to
selectively maintain mesodermal proliferation and induce fibroblast growth factor 10 (Fgf10) expression in the foregut region where the lung
forms. By using a pan-RAR antagonist (BMS493) in foregut explant cultures, we show that bud initiation is selectively blocked in the
prospective respiratory region by failure to induce Fgf10 in the corresponding mesoderm. The RA regulation of Fgf10 expression occurs only
in this region, within a defined developmental window, and is not seen in other foregut derivatives such as thyroid and pancreas where Fgf10
is also required for normal development. Furthermore, we show that RA activity is essential in the lung field to maintain lung cell identity in
the endoderm; RAR antagonism disrupts expression of thyroid transcription factor 1 (Ttf1), an early marker of the respiratory region in the
endoderm, and surfactant protein C (Sp-C) mRNAs. Our observations in mouse foregut cultures are corroborated by data from an in vivo
model of vitamin A deficiency in rats. Our study supports RA as an essential regulator of gene expression and cellular activities during
primary bud formation.
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By the end of gastrulation, the gut endoderm is patterned
along its anterior–posterior (A–P) axis and organ-specific
domains are defined that subsequently develop into organ
primordia. Among the structures that originate from the
foregut are the thyroid, thymus, the respiratory and digestive
tracts (Wells and Melton, 1999).
Retinoic acid (RA) signaling regulates a variety of path-
ways essential for pattern formation, cellular survival,
differentiation and proliferation during organogenesis
(reviewed in Chambon, 1996). The RA effects in gene0012-1606/$ - see front matter D 2004 Elsevier Inc. All rights reserved.
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heterodimers, which are widely expressed in the embryo
(Kastner et al., 1997; Mollard et al., 2000a). Analysis of an
RA response element (RARE) lacZ reporter mouse indicates
that RA signaling is already active by late gastrulation, at
embryonic day 8 (E8) (Rossant et al., 1991). Endogenous
RA synthesis begins around this time, as demonstrated by
expression of retinaldehyde dehydrogenase 2 (Raldh2), the
critical RA-generating enzyme in the early embryo (Nie-
derreither et al., 1999; Zhao et al., 1996). Studies in a
number of species suggest that endogenous RA contributes
to regionalization of the developing foregut endoderm. In
zebrafish, there is a critical RA-dependent stage for speci-
fication of hepatopancreatic progenitors (Stafford and
Prince, 2002). In mice, patterning of the endoderm of the
pharyngeal arches requires retinoid signaling (Matt et al.,
2003; Wendling et al., 2000). Analysis of Raldh2 null
mutants show that development of the posterior pharyngeal
region and corresponding pouch-derived organs, such as the
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reither et al., 2003).
Lineage studies in reporter mouse suggest that lung cell
fate is also established early after gastrulation (Perl et al.,
2002). Lung morphogenesis, however, starts much later, at
around E9.5 with the emergence of two buds in the ventral
lateral region of the mid-foregut (Wessels, 1970; reviewed
in Cardoso, 2001; Hogan, 1999). In the developing foregut,
Raldh2 transcripts are abundant and RARElacZ activity is
present in all layers, including the region where the pre-
sumptive lung forms (Malpel et al., 2000; Niederreither
et al., 2003; Rossant et al., 1991). Subsequently, however,
RA signaling is downregulated in the lung primordia, first
in the mesenchyme and then in the epithelial layer during
branching (Malpel et al., 2000).
An important role for RA in the embryonic lung is
implied by the dramatic respiratory tract defects described
in compound RARa/RARb or RARa/RXRa knockout mice,
in vitamin A-deficient rats, or in mouse embryos treated
with pharmacologic inhibitors of RAR signaling (Dickman
et al., 1997; Kastner et al., 1997; Mendelsohn et al., 1994;
Mollard et al., 2000a; Wendling et al., 2000; Wilson et al.,
1953). These abnormalities include unilateral or bilateral
lung hypoplasia and, in more severe cases, lung agenesis.
Little is known about the signaling events controlled by RA
at the onset of lung development and the molecular mech-
anisms involved in these respiratory tract defects remain
elusive.
There is evidence that a regulatory network of endoder-
mal and mesodermal signals that includes fibroblast growth
factors (FGF), TGF beta superfamily members and tran-
scription factors from the Gli and T-box families is estab-
lished in the presumptive respiratory region of the mid-
foregut to induce lung development (Bellusci et al., 1997b;
De Moerlooze et al., 2000; Motoyama et al., 1998;
Sakiyama et al., 2003; Sekine et al., 1999; and reviewed
in Cardoso, 2001). The roles of many of these signals in the
embryonic lung have been recently elucidated by genetic
models. For example, fibroblast growth factor 10 (Fgf10)
and its cognate receptor Fgfr2b are critical for lung bud
formation. At E9.5, primary lung budding is initiated by
local expression of Fgf10 in the ventral lateral foregut
mesoderm and activation of Fgfr2b signaling in the endo-
derm. Genetic deletion of either Fgf10 or Fgfr2b results in
lung agenesis (De Moerlooze et al., 2000; Min et al., 1998;
Sekine et al., 1999). Other genes such as sonic hedgehog
(Shh) and the thyroid transcription factor 1 (Ttf1, or Nkx 2.1)
are expressed by respiratory progenitor cells in the ventral
foregut endoderm even before lungs buds form. These
genes, however, are not required to induce primary buds
and have been associated with other events, such as branch-
ing morphogenesis and differentiation. Lungs from Ttf1
knockout mice grow as paired non-branched endodermal
sacs without expression of known lung-specific cell markers
(Minoo et al., 1999). Targeted deletion of Shh also results in
branching defects. However, unlike Ttf1mutants, proximal–distal lung epithelial differentiation still occurs in Shh
knockout mice (Litingtung et al., 1998; Peppicelli et al.,
1998).
While it is known that these signals co-exist with
components of the RA pathway in the foregut, there is little
information about their regulation by retinoids when lungs
are forming and how relevant these interactions are for lung
morphogenesis. To investigate these issues, we disrupted
retinoid signaling in the developing foregut in vitro before
the onset of lung morphogenesis. Here, we provide evidence
that the mechanism by which RA regulates early lung
development involves promotion of mesodermal cell prolife-
ration and selective induction of Fgf10 gene expression in
the prospective lung field. We show that the dependence of
Fgf10 on RA is selective for the mid-foregut region, and
occurs within a defined developmental window before
primary budding. Fgf10 expression then becomes indepen-
dent of RA and, as previously reported, it is inhibited by
retinoid signaling during branching morphogenesis (Bel-
lusci et al., 1997b; Malpel et al., 2000).
Moreover, we found that RA is essential to maintain lung
endodermal cell fate in the nascent bud. We have evidence
that this effect is at least in part mediated by Fgf10
activation of the Fgf pathway in the endoderm to promote
expansion of lung endodermal progenitor cells. These con-
clusions are corroborated by data from an in vivo model of
vitamin A deficiency in rats in which disruption of RA
signaling also causes lung agenesis. Our study suggests that
RA is critical for regulation of the gene network in the
prospective respiratory region of the mid-foregut during
lung morphogenesis.Materials and methods
Foregut cultures
Timed pregnant CD1 (Charles River) or RARElacZ
reporter mice (below) were sacrificed at gestational day
8.5 (E8.5); embryos were individually staged by number of
somites. Most experiments were performed in 8- to 15-
somite-stage embryos. Foreguts were isolated in PBS using
tungsten needles. Extra embryonic tissues and dorsal struc-
tures were removed while lateral and ventral regions were
left intact, including the heart (see diagram in Figs. 1A, B,
E). Explants were cultured for 1–6 days on Costar 6-well
Transwell-Col dishes containing 1.5 ml of BGJb medium
(GIBCO-BRL), 10% fetal calf serum (GIBCO-BRL) and 20
mg/ml ascorbic acid (Sigma) with or without BMS493 or
all-trans RA (Sigma). Cultures were shielded from light and
incubated at 37jC in 95% air and 5% CO2. Medium was
changed daily. In some experiments, heparin beads soaked
in human recombinant FGF10 (100 ng/Al, R&D Systems) or
PBS (buffer) were grafted onto foreguts after 48 h culture.
Preliminary experiments showed that under control condi-
tions E8.5 foreguts properly develops primary lung buds
Fig. 1. (A, B) Diagram shows expression of RARElacZ transgene along the anterior–posterior (A–P) axis of the mouse foregut at E8.5; foregut region used for
culture is indicated in white. Colored lines depict presumptive organ-specific domains that will give rise to thyroid (Th), (ANTERIOR), lung (Lu) and stomach
(St) (MID) and liver (Li) and pancreas (P) (POSTERIOR). (C, D) Overlapping domains of expression of Raldh2 and lacZ in E9.5 foregut, by whole mount ISH
and X-gal staining, respectively. (E) Diagram represents the explant at the start of culture with foregut (Fg) and adjacent heart (ht) (E8.5 + 0 h). (F–H) lacZ
expression in control (Ctrl) foregut cultures a day later (E8.5 + 24 h) shows a pattern of staining reminiscent of the E9.5 in vivo; (F) this contrasts with the weak
staining in BMS493-treated (G), and ubiquitous signaling in all-trans RA-supplemented (H) conditions (both at 106 M). Red line in C, D, F–H depicts
anterior boundary of expression of Raldh2 or lacZ originally seen in vivo or in control explants. Scale bar represents 250 Am.
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ing morphogenesis in vitro only when explants are isolated
at later stages (>E9.0). Explants were processed for X-gal
staining (reporter mice) or fixed in 4% paraformaldehyde at
4jC overnight, and stored at 20jC in 100% methanol for
whole mount in situ hybridization (ISH) studies, or paraffin-
embedded for immunohistochemistry (see below).
Modulation of RA signaling
We used the pan-RAR antagonist BMS493 (Bristol
Meyers Squibb) and all-trans RA (Sigma) dissolved in
BGJb medium at a final concentration of 106 M. The
efficacy of BMS493 in antagonizing signaling by all RARs
at this concentration, without toxicity, has been previously
demonstrated (Mollard et al., 2000b; Wendling et al., 2000).
Compounds were reconstituted in ethanol and stored at
70jC in light-protected conditions.
Vitamin A-deficient rats
Animals were generated as described (Power et al., 1999)
using Sprague–Dawley rats depleted of retinoid stores using
a retinoid-deficient diet (Dickman et al., 1997). Offspring
were fed this same diet, with oral RA supplementation (20
and 100 Ag daily) as depletion progressed. These progeny
were mated and received oral RA supplementation (100 Agdaily, twice daily from E5.5) until E7.0, when it was either
withdrawn (RA deficient, RAD) or continued (RA suffi-
cient, RAS) until embryos were collected at E13.0 (38–40
somites). RAD embryos thus experienced severe retinoid
insufficiency after E7.0 and until harvested. Embryos were
fixed in 4% paraformaldehyde and paraffin-embedded for
subsequent analysis. RAS and RAD embryos were matched
according to number of somites.
RARElacZ reporter mice
These animals have been characterized by Rossant et al.
(1991). They carry the bacterial lacZ gene under the control
of a heat shock promoter (hsp 68) and the RA-responsive
element (RARE) from the RAR-h promoter. LacZ is
expressed at sites where RA activates RARs. h-Galactosi-
dase staining was performed overnight using X-gal as
substrate as described in Malpel et al. (2000). After stain-
ing, some explants were processed for histological analysis
of 6-Am paraffin sections.
In situ hybridization
Whole mount and isotopic ISH were performed as
described in Wilkinson (1992). For whole mount procedures
(mouse embryos and cultured foregut explants), we used
digoxigenin (DIG)-labeled riboprobes (Maxiscript kit,
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Fgf10, Fgfr2b, Albumin, Bmp4, Pax8, Pdx1, Ptch, Raldh2,
Shh, Sp-B, Sp-C and Ttf1. Briefly, embryos or foregut
explants were rehydrated, digested with Proteinase K, pre-
hybridized for 1 h at 70jC in buffer containing 50%
formamide, 5 SSC, 1% SDS, 50 mg/ml of yeast RNA
and heparin followed by overnight hybridization with DIG-
labeled RNA probes. Samples were then incubated with
anti-DIG alkaline phosphatase conjugate overnight at 4jC.
Signal was visualized with BM Purple substrate solution
(Roche Diagnostics), according manufacturer’s protocol.
After staining, some specimens were processed for histo-
logical analysis. Isotopic ISH was performed on 5-Am
paraffin sections of rat embryos using 35S-labeled Fgf10
riboprobe. Sections were rehydrated, digested with Protein-
ase K, hybridized overnight at 50jC and washed. Autora-
diography was performed by dipping sections in
photographic emulsion (Kodak NTB-2). Sections were
developed after a 3-week incubation period at 4jC. Expres-
sion patterns reported here were consistently seen in at least
three to four specimens.
Cell proliferation and cell death assay
Cell proliferation was evaluated by assessment of PCNA
(cell proliferation kit, Zymed); apoptosis was assessed by
TUNEL (Apoptag kit, Intergen) assay and Caspase 3
immunohistochemistry (below). All stains were performed
in paraffin sections of foregut explants using the kits above
and the DAB staining kit (Vector Laboratories), according to
the manufacturer’s recommendations. Sections were coun-
terstained with methyl green. We used PCNA- and TUNEL-
stained sections to estimate the number of cells undergoing
proliferation or apoptosis in the lung field in both endoderm
and mesoderm. We counted labeled and unlabeled cells in
six to nine nonoverlapping lung fields at 100 magnifica-
tion in sections of controls (bud and stalk) and BMS-treated
(non-budded region) of three explants each. We used a
similar approach to quantitate endodermal and mesodermal
PCNA and TUNEL labeling in BMS-treated explants
engrafted with either control (PBS) or FGF10-soaked beads.
Results were expressed as percentage of total cells in each
layer (mesoderm or endoderm). By Student’s t test, differ-
ences were considered statistically significant if P < 0.05.
Immunohistochemistry
Immunostaining was performed using standard proce-
dures in 5-Am paraffin sections. Ttf1 expression was
detected using anti-Ttf1 antibody (Dako Corporation,
#M3575, 1:100 dilution) and goat anti-mouse IgG1 conju-
gated with Texas Red (Southern Biotech #1070-07, 1:100),
as directed by the manufacturer. Caspase 3 was detected
using an anti-human-mouse antibody #AF835 (R&D Sys-
tems, 0.5 Ag/ml dilution, overnight at 4jC) and the IgG
Vectastain and DAB staining kits from Vector LaboratoriesResults and discussion
To investigate how endogenous RA influences primary
lung bud formation, we designed in vitro loss of function
experiments using foregut explants from E8.5 CD1 and
RARElacZ reporter mouse embryos (ages ranging from
8- to 12-somite stage). At E8.5, lung buds are not present
and endodermal markers of lung development are not
detectable by in situ hybridization (ISH); lung cell fate,
however, may have been already specified (Perl et al.,
2002). The pancreas is specified by the eight-somite stage,
but no buds are present before the 20- to 25-somite stage
(Deutsch et al., 2001; reviewed in Kumar and Melton,
2003). Thyroid and liver rudiments are forming and
express molecular markers (Kimura et al., 1996; Rossi
et al., 2001). There is evidence of RA synthesis and
utilization throughout the foregut including the presump-
tive lung, stomach, pancreas and liver fields (Malpel et al.,
2000; Niederreither et al., 2003; Rossant et al., 1991). A
sharp boundary of expression of the RA synthesizing
enzyme Raldh2 and RARElacZ activity approximately at
the level of the first somite limits RA signaling in the
anterior foregut (Figs. 1C, D). RA signaling is excluded
from the thyroid primordia.
Disruption of RA signaling selectively inhibits lung bud
induction and stomach formation
First, we determined whether under our culture condi-
tions lacZ expression faithfully reproduced the status of RA
activation of the foregut. X-gal staining of explants from the
reporter mouse when cultured in control medium (18–72 h)
exhibit a pattern of lacZ expression reminiscent of that seen
in vivo (Figs. 1D, E9.5; F, E8.5 + 24 h). Treatment with the
pan-RAR antagonist BMS493 at 106 M results in near loss
of lacZ expression within 18–24 h, as previously demon-
strated in other systems (Fig. 1G; Mollard et al., 2000b;
Wendling et al., 2000). Conversely, supplementation with
all-trans RA (106 M) induces strong generalized reporter
gene activation (Fig. 1H).
We compared foregut development in E8.5 explants
growing in control and BMS-containing media up to 6
days. We focused on the lung, thyroid and liver-pancreas
as representative structures of the mid-, anterior and poste-
rior foregut regions, respectively (Figs. 1A, B). In control
cultures, these organ primordia are consistently identified by
day 3 by morphologic criteria and expression of molecular
markers (n > 10; Fig. 2A and below). lacZ expression is
mostly seen in the endoderm (Figs. 2B, C). BMS treatment
dramatically disrupts lung and stomach development, with-
out apparently affecting the thyroid, liver or pancreas (n >
10; Figs. 2D–G). At day 3 or subsequent days, no lung buds
are present in the presumptive respiratory tract region.
Histological analysis reveals a tube lined by a tall columnar
epithelium without evidence of morphologic differentiation
(Fig. 2E). The lung epithelial marker genes surfactant
Fig. 2. Foregut organogenesis in vitro and effects of BMS493. (A) Control foregut culture at day 3; thyroid (Th) and liver (Li) morphogenesis already initiated
at day 0, whereas lung (Lu), stomach (St) and pancreas (Pv, ventral; Pd, dorsal) initiated in culture. (B, C) X-gal staining of day 3 control RARElacZ cultures
shows strong signals throughout the endoderm, with the exception of the anterior foregut where the thyroid forms (red dotted line). Histological section (C)
confirms observations in whole mounts. (D–H) Selective disruption of lung (*) and stomach morphogenesis in BMS493-treated cultures at day 3. (E) H&E
staining shows a tube lined by columnar epithelium where lung buds failed to form, with thyroid (F) and pancreatic buds (G) apparently normal. (H) X-gal
staining confirms loss of RA signaling at day 3 (compare with B). (I –L) Sp-C and Sp-B transcripts are present in the distal lung buds of controls, but absent (*)
in BMS-treated cultures. (M–P) Pdx1 labels ventral and dorsal pancreatic primordia at E9.5 in vivo (M) and is expressed in both control (N) and BMS-treated
(O) explants at comparable levels. (P) Histological section of O confirms Pdx1 expression in dorsal pancreas of BMS-treated explants. Scale bars in A, E and I
represent 220, 70 and 400 Am, respectively.
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controls, but not in BMS-treated cultures (Figs. 2I–L).
BMS-induced toxicity was ruled out by several criteria
including cellular integrity, TUNEL staining, and reversibil-
ity of the effects (described below).
The generalized loss of RA signaling (Fig. 2H) does not
prevent dorsal or ventral pancreatic buds from being in-
duced, and the early pancreatic endodermal maker, homeo-box gene Pdx1, is expressed as in controls (Figs. 2G and
M–P; reviewed in Kumar and Melton, 2003). The data
suggest that RA signaling is not critical for triggering
pancreatic bud morphogenesis or for maintaining the pan-
creatic endodermal fate when buds are forming. We could
not detect differences in bud morphology or gene expression
between control and BMS-treated explants in the liver (data
not shown) or thyroid (see below). BMS-induced changes in
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they have been previously characterized elsewhere (Wen-
dling et al. 2000; Matt et al., 2003).
Interestingly, BMS disrupts primary lung bud induction
within a limited developmental window only when foreguts
are placed in culture before the 15-somite stage. Antago-
nizing RA signaling after this stage, yet before morphoge-
nesis has initiated, does not perturb either primary lung
budding or stomach formation (n > 10). In contrast, excess
retinoid (RA-containing medium up to 106 M) does not
affect bud formation at any of the stages tested here (n > 10,
see below in Figs. 3 and 4).
RA signaling regulates Ttf1 expression in the prospective
lung endoderm but not in the thyroid
To investigate whether the endoderm of the BMS-treated
explant retained the identity of early lung cell progenitors,
we assessed expression of Ttf1 mRNA in our system. Ttf1
is the earliest known marker of the respiratory lineage and
labels the region where the lung will form in the develop-
ing foregut endoderm. Ttf1 mRNA expression precedes Sp-
C and Sp-B, which are detectable by ISH only after lung
bud morphogenesis begins (Kimura et al., 1996; Minoo et
al., 1999; Wert et al., 1993). Fig. 3A shows that in the E8.5
foregut Ttf1 transcription is restricted to the nascent thy-
roid. At E9, however, an additional posterior domain ofFig. 3. Whole mount ISH of Ttf1 and Pax8 mRNA in the foregut in vivo and in
demonstrates induction in thyroid and, subsequently, at E9–9.5 in the prospective r
Control cultures show strong Ttf1 signals in thyroid and lung. (E, F) Signals are ma
regardless if bud morphogenesis is blocked (E, cultures starting before the 15-s
supplemented (G) cultures express Ttf1 at comparable levels. (H–K) Pax8 labels th
by RA signaling in foregut cultures as shown in (I–K). Scale bar in D representexpression appears in the presumptive respiratory field
(Figs. 3A–C).
Whole mount ISH of 3-day control cultures shows Ttf1
mRNA signals in both thyroid and lung buds (Fig. 3D). In
BMS-treated cultures, Ttf1 expression is unaffected in the
thyroid primordium but is significantly reduced in the
respiratory region of the endoderm that failed to bud (Fig.
3E). To distinguish thyroid from lung endoderm in these
cultures, we assessed expression of the transcription factor
Paired box 8 (Pax8) (Plachov et al., 1990). As shown by
Figs. 3H, I, Pax8 labels the thyroid but not the lung
primordia of E8.5–9.5 embryos or control cultures. Like
Ttf1, Pax8 gene expression in thyroid is not disrupted by
BMS treatment (Fig. 3J). Together, the presence of Ttf1 and
Pax8 transcripts and the absence of lacZ signals in the
anterior foregut suggest that early thyroid development is
independent of endogenous retinoids (Figs. 1A, B, and
Rossant et al., 1991). Neither lung nor thyroid gene expres-
sion in the foregut appears to be affected by high levels of
RA. Culturing explants in exogenous RA (106 M) has no
obvious effect on levels or distribution of Pax8 or Ttf1 at the
stages we assessed (Figs. 3G, K).
Our model shows that disrupting RA signaling in the
8- to 15-somite-stage foregut blocks budding and attenuates
Ttf1 mRNA expression in the presumptive lung endoderm.
Analysis of explants in which BMS treatment is initiated
after the 15-somite stage showed that, although not affectingvitro (A–C). Developmental expression of Ttf1 in E8.5 foregut endoderm
espiratory tract, persisting in epithelium of the nascent trachea and lung. (D)
rkedly attenuated by BMS treatment in the respiratory field, but not thyroid,
omite stage) or proceeds (F, day 0 older than 15s). Control (D) and RA-
e thyroid but not the lung epithelium in the E9.5 foregut and is not regulated
s 350 Am.
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(Fig. 3F). These results suggest that endogenous RA main-
tains an early program of differentiation in lung endodermal
progenitor cells that includes expression of genes, such as
Ttf1 and presumably Sp-C. Ttf1 is required to induce Sp-C
gene expression (Kelly et al., 1996; Minoo et al., 1999).
Moreover, we have shown that constitutive activation of
RAR a signaling in putative progenitor epithelial cells of
the distal lung maintains high levels of Ttf1 and Sp-C
mRNA expression in vivo (Wongtrakool et al., 2003).
Fgf10 expression is dependent on RA in the lung field but is
RA-independent in the thyroid and pancreatic fields
Formation of the lung bud from the foregut is critically
influenced by the signaling of Fgf10 through Fgfr2b (De
Moerlooze et al., 2000; Sekine et al., 1999). We investigated
whether antagonizing RA signaling caused the defect seen
in BMS-treated cultures by disrupting the Fgf pathway. InFig. 4. Whole mount ISH of Fgfr2b and Fgf10 mRNA in vivo and in foregut c
including the respiratory tract in E9.5 embryos and in (B) control cultures. (B, C) F
expressed in the mesoderm of thyroid; subsequently (E9.5), signals appear in lung
(F) BMS treatment of explants younger than the 15-somite stage, but not older tha
mesoderm (*). RA (106 M) has no obvious effects on Fgf10 expression. Area be
expression. Scale bars in A and E represent 85 and 150 Am, respectively.the E8.5–9.5 foregut, Fgfr2b is expressed throughout the
endoderm and continues to be expressed in the epithelium of
the forming lung, thyroid and pancreas both in vivo and in
vitro (Fig. 4A; Orr Urtreger et al., 1993). Our whole mount
ISH analysis shows that BMS treatment does not interfere
with endodermal expression of Fgfr2b. Signals are consis-
tently present in the non-budded endoderm, at levels com-
parable to buds in controls (Figs. 4B, C).
Next, we examined Fgf10 expression. In the early E8.5
foregut, Fgf10 mRNA is present in the anterior mesoderm
associated with the forming thyroid (Fig. 4D). By E9.5,
when the lung and pancreas begin to bud, Fgf10 transcripts
are found in association with the thyroid, lung and pancre-
atic buds. These domains of Fgf10 mRNA remain intact in
explants cultured under control conditions for at least 3
days (Fig. 4E). In BMS-treated explants, expression of
Fgf10 mRNA is preserved in areas near the thyroid and
pancreas, but there is no detectable expression in the
mesoderm near where the lung and stomach are expectedultures. (A) Fgfr2b mRNA is expressed throughout the foregut endoderm
gfr2b expression is not disrupted by BMS treatment. (D) At E8.5, Fgf10 is
and thyroid domains. (E) In control cultures, these domains are preserved.
n that (G), prevents Fgf10 mRNA expression in the presumptive respiratory
tween dotted lines (in yellow) corresponds to the region of disrupted Fgf10
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the Fgf10 receptor is not affected by BMS, expression of
the Fgf10 ligand is blocked by BMS in the presumptive
lung field.
We asked if there is a critical developmental window in
which Fgf10 is under the control of RA signaling. We found
that BMS treatment effectively inhibits Fgf10 mRNA and
bud formation in explants younger, but not older than the
15-somite stage (Fig. 4G). This indicates that by the 15-
somite stage, RA signaling has already activated the mo-
lecular pathways required to induce local expression of
Fgf10 mRNA and early lung morphogenesis. Continued
BMS treatment for up to 6 days does not seem to affect
levels or spatial distribution of Fgf10 transcripts, nor does
exogenous all-trans RA (Fig. 4H). These data strongly
suggest that RA signaling is required to induce, but not to
maintain, Fgf10 expression. This contrasts with the inhibi-
tory effect of BMS on Ttf1 transcription in the lung field
(see Fig. 3F) which is found at all stages. The presence of
mesodermal RARElacZ activity during normal development
(Figs. 1A, D, F) suggests that RA acts directly in this layer
to initiate Fgf10 mRNA transcription. Nevertheless, further
experiments are required to confirm this hypothesis.
Whole mount ISH analysis did not reveal obvious differ-
ences in the expression pattern of Shh, its receptor Patched
(Ptch), or bone morphogenetic protein 4 (Bmp4), genes
known to be regulated by RA and to interact with Fgf10
(Bellusci et al., 1997a,b; Lebeche et al., 1999; Malpel et al.,
2000; data not shown).
BMS inhibits foregut apoptosis and mesodermal cell
proliferation in the lung field
We asked whether in the lung domain BMS interfered
with the ability of foregut cells to proliferate normally or to
survive. We compared the pattern of PCNA labeling of the
endoderm and mesoderm of this region in control and BMS-
treated explants. Fig. 5A shows that in day 4 controls,
labeling is typically present in both germ layers and is
greater at the bud tip than at the stalk. In BMS cultures,
PCNA labeling is clearly present in the endoderm, but is
much diminished in the mesoderm (Figs. 5B–D). This is
consistent with our morphometric analysis (Fig. 5D), which
shows a significant decrease in the relative number of
PCNA positive cells in the mesoderm (Control = 34% and
BMS = 13%), but not in the endoderm (Control = 40% and
BMS = 38%). The inhibitory effect of BMS on mesodermal
proliferation seems to selectively occur in the foregut, given
that PCNA labeling of the neighboring cardiac mesenchyme
looks overall preserved (Fig. 5B).
PCNA labeling in the endoderm suggests that BMS
treatment still allows endodermal growth in the lung field
(Fig. 5B) via RA- and Fgf10-independent pathways. How-
ever, by blocking Fgf10 expression, BMS likely prevents
FGF-mediated expansion of lung endodermal progenitors
required for lung bud induction. Indeed, when compared tocontrols, BMS-treated explants have less cells [(meanF se):
Control = 228 F 14; BMS = 147F 9.4] and less PCNA-
labeled profiles (absolute number of cells: Control: endo-
derm = 41 F 14, mesoderm = 43 F 11; BMS: endoderm =
17 F 2; mesoderm = 14 F 2) in the lung field.
To assess if loss of endogenous RA signaling resulted in
selective cell death in the foregut, we performed TUNEL
staining in BMS-treated explants sequentially at days 1, 2
and 4 in culture. We did not find evidence of increased
foregut apoptosis in the expected lung region at any of these
time points; rather, BMS appears to prevent local cell death
(Figs. 5F–H). Fig. 5E illustrates the staining pattern in the
lung field of 4-day control cultures. A small proportion of
TUNEL-labeled cells is present in the endoderm (about 5%)
and the mesoderm (about 15%) of controls. With BMS,
TUNEL is significantly decreased in both layers in the
presumptive lung field. This is particularly evident in the
mesoderm, where only 0.4% of cells were stained (Fig. 5H).
The selective effect of BMS in the foregut is indicated by
the presence of TUNEL-positive cardiac mesenchymal cells
flanking an overall unlabeled foregut (Fig. 5F). The BMS
effect of reducing cell death was confirmed by immunos-
taining with Caspase 3, another marker for apoptosis (Thi-
bert et al., 2003; data not shown).
Together, these results suggest that, without RA signal-
ing, mesodermal cells in the lung field are kept viable but
quiescent, and thus, unable to proliferate and transcribe
Fgf10. Endogenous RA appears to be less important for
endodermal proliferation and overall growth of the foregut
endoderm. This is consistent with the observation that size
of the explants was comparable in both groups. The data
also indicate that disrupted budding and Ttf1 transcription
by BMS does not result from selective death of lung
endodermal cell progenitors.
FGF10 rescues lung bud morphogenesis and endodermal
differentiation in the absence of RA signaling
Our data suggest that the failure to form lungs results
primarily from the inability of the mesoderm to induce
Fgf10 expression. While the lack of Fgf10 could by itself
explain the failure to induce budding, it was unclear whether
lung endodermal progenitor cells were competent to re-
spond to Fgf10 and activate the Fgfr2 pathway in the
absence of RA signaling. Furthermore, because both path-
ways were disrupted in BMS-treated cultures, we could not
distinguish the effects caused by the lack of Fgf10 from
those that resulted from loss of retinoid signaling. To
address these issues, we cultured E8.5 (<15 somites) foregut
explants in control or BMS-containing media; heparin beads
soaked in either control buffer (PBS) or human recombinant
FGF10 (R&D, 100 ng/Al) were then engrafted nearby the
presumptive lung field. As expected from previous reports
in other developing systems (Park et al., 1998; Weaver et al.,
2000), FGF10 elicits local budding in the foregut endoderm
of controls (Fig. 6A and data not shown).
Fig. 5. PCNA (A–D) and TUNEL (E–H) of the lung field in foregut cultures at day 4. (D, H) Graphics represent the percentage of labeled cells (mean and
standard error) in each layer (endoderm, mesoderm) of control and BMS-treated explants. (A) In controls, PCNA labeling is present in both layers and is
increased at the bud tips. (B) BMS treatment markedly reduces PCNA labeling in foregut mesoderm, but not endoderm; labeling is preserved in heart (ht)
mesoderm. (E) TUNEL staining of control explants reveals labeling in mesoderm and endoderm, whereas BMS-treated explants (F–G) show minimal labeling
in the foregut. Arrowheads and asterisks indicate positive and negative staining, respectively. Ctr, control; fg, foregut; ht, heart; Lu, lung. Scale bar in B
represents120 Am. Asterisks in graphics (D, H) indicate statistical significance (P < 0.05).
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ing beads rescue bud formation. Figs. 6A, G show promi-
nent PCNA labeling in the endoderm associated with the
FGF10-loaded beads. This contrasts with the explants that
failed to bud, where there is no obvious association of
endodermal proliferation with the PBS control bead (Fig.
6D). Morphometric analysis reveals a significant increase in
the relative number of PCNA-labeled cells in the endoderm
adjacent to the FGF10, as compared to the PBS bead (PBS =
27%, FGF10 = 57%; Fig. 6H). Recombinant FGF10 does
not rescue mesodermal proliferation in BMS-treated
explants, as indicated by the minimal labeling near the
FGF10-loaded bead (Fig 6G), and by the relative numberof labeled cells in the mesoderm similar in both groups
(PBS = 8.6%, FGF10 = 8.6%; Fig. 6H). This was expected
since expression of Fgfr2b, which transduces Fgf10 signal-
ing, is restricted to the endoderm. Morphometric analysis of
TUNEL-stained sections shows that in BMS-treated
explants apoptosis is not significantly altered in either germ
layer by engraftment of an FGF10 bead (Figs. 6I, J). This
suggested that activation of the Fgfr2b pathway with exog-
enous FGF10 rescued proliferation but did not influence
apoptosis in the lung field.
Next, we examined differentiation. Whole mount ISH
analysis shows that both epithelial markers Ttf1 and Sp-C
are strongly expressed by the epithelium near the FGF10
Fig. 6. Exogenous FGF10 rescues lung budding and epithelial differentiation in BMS-treated cultures. PCNA staining in sagittal sections (A, D) and whole
mount ISH of Ttf1 (B, E) and Sp-C (C, F) in 6-day cultures engrafted with heparin beads (human recombinant FGF10, PBS buffer). (A) FGF10 beads induced
lung bud formation, local PCNA labeling and expression of Ttf1 (B) and Sp-C mRNA (C) in BMS-treated explants. PBS beads failed to induce a local increase
in proliferation (D) and had no detectable Ttf1 (E) or Sp-C (F) signals in the respiratory region of foregut. Note the preserved Ttf1 staining in thyroid (B, E).
(G–J) Quantitative analysis of PCNA- and TUNEL-stained sections from BMS-treated explants in the lung field. (H) Engraftment of an FGF10 bead results in
a significant increase in the relative number of PCNA-labeled cells in the adjacent endoderm (G) as compared to a PBS bead. Mesodermal PCNA (G) or
TUNEL labeling (I) in endoderm or mesoderm is not altered by FGF10. Graphs (H, J) represent mean and standard error; *P < 0.05. Lu, lung; Th, thyroid.
Scale bar in E represents 240 Am.
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suggests that recombinant FGF10 alone is sufficient to
maintain lung endodermal cell fate in the absence of RA
signaling. By contrast, after 6 days, neither Ttf1 nor Sp-C
transcripts can be detected in the lung field of BMS-treated
explants engrafted with PBS beads (Figs. 6E, F). Preserved
Ttf1 signals in the developing thyroid confirmed the site-
specific inhibitory effect of BMS in the lung field.
Studies in Fgf10 null mutants indicate that maintaining
the proliferative capacity of the pancreatic primordia isessential for normal pancreatic differentiation. Fgf10-medi-
ated proliferation of the early pancreas is required to
generate a quantitatively normal pool of epithelial progeni-
tors available for subsequent differentiation (Bhushan et al.,
2001). Our data are consistent with the idea that a similar
mechanism takes place in the lung primordia. Thus, we
propose that RA signaling is required to induce Fgf10,
which will then expand an initial pool of Ttf1 and Sp-C
expressing endodermal cells to generate lung differentiated
phenotypes. The presence of PCNA labeling, Ttf1 and Sp-C
T.J. Desai et al. / Developmental Biology 273 (2004) 402–415412transcripts in the epithelium associated with the FGF10 bead
in rescued lung buds supports this hypothesis.
Vitamin A deficiency recapitulates the lung agenesis and
site-specific changes inTtf1 and Fgf10 expression of
BMS-treated cultures
We asked whether what we observed in our BMS-
treated foregut cultures could be also seen by disrupting
RA signaling in vivo. To investigate this issue, we charac-
terized the lung defect of a well-established model of
vitamin A deficiency in rats (Dickman et al., 1997; Power
et al., 1999). This model was suited for comparisons
because the temporal depletion of RA in the rat embryo
is targeted to the beginning of organogenesis and becauseFig. 7. Lung agenesis and disrupted expression of Ttf1 protein and Fgf10 mRNA i
and Ttf1 immunostaining of transverse sections of control RAS foregut demonstrat
to the ventrally located tracheal epithelium and, more caudally, (B) primary lung
irregularly shaped (*) and shows low levels of Ttf1 expression in the ventral endod
signals, however, are present in the thyroid bud. (E, F) Isotopic ISH of Fgf10 m
demonstrates localized signal in the mesoderm of the lung (F, enlarged), limb and
limb and urogenital tract but is disrupted in the presumptive lung field of the fore
lung; Th, thyroid; Tr, trachea; RAD, RA deficient; RAS, RA sufficient; ug, uroge
respectively. Arrowheads represent signals; asterisks indicate areas that failed to
respectively.embryos with severe RA deficiency (RAD) also do not
form lungs.
RAD rat embryos at E13 typically illustrate this defect.
Figs. 7A, B (left panels) shows H&E staining of RA
sufficient (RAS, control) embryos with normal tracheoeso-
phageal separation and lung buds. In RAD embryos at a
corresponding age, the respiratory and digestive tracts do
not separate, the thyroid bud is present; however, only a
single tube of irregular shape is seen where the lung is
expected to develop (Fig. 7D).
Immunohistochemical analysis of Ttf1 in control RAS
embryos shows strong signals in the respiratory tract epi-
thelium. Ttf1 is present in the developing trachea and in
lung buds (Figs. 7A, B, right panels). In RAD embryos,
Ttf1 staining is markedly decreased in the presumptiven the respiratory region of foregut of vitamin A-deficient rats (A–D). H&E
es (A) ongoing tracheoesophageal separation with Ttf1 expression restricted
bud epithelium intensely labeled with Ttf1. (C) In RAD foregut, the tube is
erm at the prospective respiratory region that failed to bud. (D) Strong Ttf1
RNA in transverse sections at the level of the lung buds in control RAS
urogenital tract (ug). In RAD (G, H), Fgf10 expression is preserved in the
gut (H, high magnification). Es, esophagus; fl, forelimb; hl, hindlimb; Lu,
nital ridge. Dashed boxes in E and G delineate close-up views in F and H,
bud or to express Fgf10. Scale bars in B and G represent 80 and 480 Am,
Fig. 8. Proposed model for the role of RA in early lung morphogenesis.
Early in mouse foregut organogenesis, RA signaling is active in all layers.
(A) By the 15-somite stage, RA has induced proliferation of a critical mass
of mesodermal cells in the lung field, while signaling in endoderm
maintains identity in lung progenitor cells (in red). (B) At around 25
somites, the condensing mesodermal cells begin to locally express Fgf10
(in green), which then activates the Fgf pathway in the endoderm to expand
the population of lung progenitor cells into a primary endodermal bud. (C)
Once secondary buds form and branching morphogenesis starts, RA
signaling is downregulated in the lung and Fgf10 expression becomes
independent of RA.
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contrast, strong signals are found in the thyroid primordia of
the same embryo (Fig. 7D, right panel). These data indicate
that the selective role of endogenous RA in regulating Ttf1
expression in lung, but not thyroid, occurs both in vivo and
in vitro.
Isotopic ISH of Fgf10 in E13 RAS controls shows high
levels of mRNA expression in the mesoderm of the devel-
oping lung, limb and urogenital tract (Figs. 7E, F). In RAD
embryos, no signals or only weak diffuse labeling is seen in
the foregut mesoderm of the presumptive lung (Figs. 7G,
H). The selective disruption of Fgf10 transcription in the
lung field is evident in Fig. 7G when compared to the strong
signals in the limb and urogenital tract. The changes in Ttf1
and Fgf10 expression and the absence of lung buds in two
different models of retinoid deficiency provide additional
support for the critical role of RA in the developing
respiratory tract.
Concluding remarks
Here, we investigated the mechanisms by which endoge-
nous RA regulates the initial events of respiratory tract
morphogenesis in the developing foregut. We provide novel
evidence that in the prospective lung field, endogenous RA
is critical to allow normal mesodermal proliferation and
induction of Fgf10 expression. We show that RA regulation
of Fgf10 occurs within a limited developmental window and
is not seen in the thyroid or pancreas, where Fgf10 is present
and required for normal development. We confirmed RA
regulation of lung bud morphogenesis, Ttf1 and Fgf10
expression in two different models, in vivo and in vitro,
and in two related species (rat and mouse).
Using our foregut culture system, we could not determine
whether endogenous RA is required for initial induction of
lung endodermal cell fate in the foregut because both RA
signaling and lung cell fate initiate before the stages we
studied here. We could not investigate this issue because
explants isolated before the eight-somite stage developed
poorly in culture. We found, however, that RAR transcrip-
tional activity is essential to maintain endodermal expres-
sion of Ttf1 in the lung field. Although also present in the
thyroid, Ttf1 expression was regulated by RA signaling only
in the lung field. This involved activation of the RA
pathway both in the endoderm and mesoderm, the latter
via induction of Fgf10 and subsequent activation of the
Fgfr2b pathway in the endoderm. Our data suggested that
these may represent two independent mechanisms. For
example, in BMS-treated explants older than 15-somite-
stage Fgf10 is transcribed at apparently control levels, but
Ttf1 expression is greatly reduced (Fig. 3F). When both
endogenous RA signaling and Fgf10 expression are down-
regulated (BMS treatment before the 15-somite stage),
exogenous FGF10 (beads in Fig. 6B) is able to rescue
Ttf1 expression. Fgf10, however, is not involved in initiation
of lung endodermal cell fate since early endodermal expres-sion of Ttf1 mRNA in the lung field precedes Fgf10
transcription in the corresponding mesoderm (Fig. 3B).
Interestingly, while in the lung primordia RA is required
to induce Fgf10, subsequently during branching morpho-
genesis, RA has been reported to inhibit Fgf10 transcription
in vitro (Bellusci et al., 1997b; Malpel et al., 2000). This
seemingly paradoxical observation reinforces the idea that
RA regulation of Fgf10 is indirect and may be mediated by
activation of one or more intermediate signals transiently
expressed in the mesoderm. The possibility that one of these
signals may belong to the T-box family of transcription
factors (Tbx) is attractive for several reasons. Tbx genes are
transcriptional targets of RA (Niles, 2003; Mic et al., 2004).
Tbx1–5 have been reported in the mesoderm of the pha-
ryngeal region or lung mesenchyme in overlapping and
nonoverlapping domains during organogenesis (Chapman
et al., 1996). Analysis of the Fgf10 promoter has identified
at least three potential Tbx binding sites within the initial 7-
kb genomic regions, which are well conserved in human and
mouse (Agarwal et al., 2003). Fgf10-luciferase reporter
assays show, for example, that TBX5 directly activates the
Fgf10 promoter, and that beta-catenin-dependent Wnt sig-
naling through LEF1/TCF1 binding sites cooperate to
maintain Fgf10 transcription (Agarwal et al., 2003). Wnt
family members and Lef/Tcf transcription factors have been
reported in the developing foregut and lung (Gavin et al.,
1990; Tebar et al., 2001). Moreover, genetic studies in vivo
and in vitro show that Tbx is critical for proper Fgf10
T.J. Desai et al. / Developmental Biology 273 (2004) 402–415414expression during limb bud induction and during respiratory
tract formation, including primary lung budding and branch-
ing morphogenesis (Cebra-Thomas et al., 2003; Naiche and
Papaioannou, 2003; Sakiyama et al., 2003). For example, in
chick foregut explants, Tbx4 misexpression induces ectopic
expression of Fgf10 and ectopic budding in the esophagus.
Nevertheless, at least another layer of complexity likely
exists, since Fgf10 transcription occurs only within a sub-
domain of the Tbx4-expressing zone in the foregut (Sakiyama
et al., 2003). Current studies aiming at the identification of
retinoid targets differentially expressed in the mid-foregut
region may clarify this issue and are underway.
In summary, our data suggest a model (Fig. 8) in which
activation of RA signaling during early stages of foregut
development contributes to maintain an early program of
lung endodermal cell fate and to produce a critical mass of
mesenchymal cells in the lung field, which subsequently
will transcribe Fgf10. Fgf10 induction of endodermal pro-
liferation and bud morphogenesis ultimately will result in
expansion of an original pool of lung progenitor cells
specified at an earlier stage. Once primary and subsequent
buds form, RA activity declines in the foregut mesoderm
and Fgf10 expression is no longer linked to RA signaling.
Fgf10 is then transcribed in the distal lung mesenchyme in a
dynamic fashion during branching morphogenesis.Acknowledgments
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